Family offices, the private investment firms that manage wealth for affluent families, have been stepping more directly into biotech this year. In August alone, they...
Biotech
A clinical stage biotechnology company working on a rare genetic disorder is about to become a public company, and the deal behind it is worth...
[stock_market_widget type=”card” template=”basic2″ assets=”ADCT” realtime=”true” api=”yahoo-finance”] Biotech companies often face a defining moment when their most important clinical trial results arrive. This is especially true...
